Design of an Escherichia coli Expressed HIV-1 gp120 Fragment Immunogen That Binds to b12 and Induces Broad and Potent Neutralizing Antibodies-Reference-Cited by-同舟云学术

Design of an Escherichia coli Expressed HIV-1 gp120 Fragment Immunogen That Binds to b12 and Induces Broad and Potent Neutralizing Antibodies

Published:2013-04 Issue:14 Volume:288 Page:9815-9825
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Bhattacharyya Sanchari,Singh Pranveer,Rathore Ujjwal,Purwar Mansi,Wagner Denise,Arendt Heather,DeStefano Joanne,LaBranche Celia C.,Montefiori David C.,Phogat Sanjay,Varadarajan Raghavan

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference62 articles.

1. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody;Kwong;Nature,1998

2. Rapid evolution of the neutralizing antibody response to HIV type 1 infection;Richman;Proc. Natl. Acad. Sci. U.S.A.,2003

3. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV. Intrinsic stability predicts lifelong persistence;Strain;Proc. Natl. Acad. Sci. U.S.A.,2003

4. GP120. Target for neutralizing HIV-1 antibodies;Pantophlet;Annu. Rev. Immunol.,2006

5. The HIV-1 envelope glycoproteins. Fusogens, antigens, and immunogens;Wyatt;Science,1998

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QTY code designed antibodies for aggregation prevention: A structural bioinformatic and computational study;Proteins: Structure, Function, and Bioinformatics;2023-10-05

2. Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis;Journal of Virology;2020-10-14

3. Influenza Hemagglutinin Head Domain Mimicry by Rational Design;The Protein Journal;2020-10

4. One-step sequence and structure-guided optimization of HIV-1 envelope gp140;Current Research in Structural Biology;2020

5. Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles;Vaccine;2018-10